-
1
Agitation and anxiety are prevalent in over 85% of Alzheimer's disease patients, particularly in later stages of cognitive impairment.
-
2
The global aging population is expected to see a significant rise in mental health disorders, with nearly 50% of those over 75 projected to suffer from such diseases by 2050.
-
3
Current treatments for mood disorders in Alzheimer's are primarily symptomatic and do not halt disease progression, posing risks for further neurological damage.
-
4
Innovative therapeutic strategies targeting shared pathways of mood disorders and cognitive loss may involve autophagy, inflammation, and gut microbiome dynamics.
-
5
The relationship between behavior disorders and cognitive diseases like Alzheimer's and multiple sclerosis highlights the complexity of their underlying biological mechanisms.
